BackAravive Overview

Aravive Profit Margin

Aravive (ARAV) has a profit margin of -1027.73%, below the Healthcare sector average of 15.58%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

770.17%
343.69% YoY

As of Sep 2023

Annual Profit Margin (TTM)

-1027.73%
47.75% YoY

Trailing 12 months ending Sep 2023

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Aravive (ARAV) FAQ

Aravive (ARAV) currently reports a profit margin of -1027.73% as of September 2023. That compares with -695.57% in the prior-year period — down 47.8% year over year. That is below the Healthcare sector average of 15.58%. Use the charts on this page to explore Aravive's profit margin history and peer comparisons.

Aravive's profit margin decreased from -695.57% to -1027.73% — a 47.8% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aravive's profit margin of -1027.73% is lower than the Healthcare sector average of 15.58%. That is roughly 6694.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Aravive's current -1027.73% should be judged against Healthcare norms (sector average: 15.58%) and against ARAV's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -1027.73%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for Aravive, and consider following ARAV for alerts when major investors trade the stock.